Aida Pharmaceuticals (AIDA) 8-K Changes in Registrant.s Certifying Accountant

Exhibit 16.1

February 2, 2006

Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, D.C. 20549

Commissioners:

We have read the statements made by BAS Consulting, Inc., which we understand will be filed with the Commission, pursuant to Item 4.01 of Form 8-K, as part of the Company's Form 8-K report dated January 24, 2006. We agree with the statements concerning our Firm in such Form 8-K.

Very truly yours,

/s/ Most & Company, LLP

Most & Company, LLP